Delivery Order SPE2DE24D0013-SPE2D625F1HRA
- Not listed
- The Defense Logistics Agency awarded a $4,080 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, influenza, and respiratory syncytial virus (RSV) testing solutions. The delivery order, designated 4569150327 and titled XPCOV2/FLU/RSV-10, carries an ultimate completion date of August 26, 2025, and was issued on August 19, 2025, with no set-aside designation. The contract represents a relatively small procurement under...
- Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, was awarded a $3,400 firm fixed-price delivery order on July 28, 2025, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) diagnostic testing supplies. The delivery order, contract number 4568910321, is set to be completed by August 4, 2025, and will be performed at Cepheid's Sunnyvale facility. The contract is funded by the Defense Department's Medical Supply Chain entity and utilizes no...
- The Defense Logistics Agency awarded a $2,992 delivery order to Cepheid Inc., a Sunnyvale, California-based manufacturer of molecular diagnostic solutions, under contract 4568960202 for COVID-19, influenza, and respiratory syncytial virus (RSV) testing supplies and services. This firm fixed-price delivery order, with no set-aside designation, is scheduled for completion by August 15, 2025, and represents procurement of diagnostic reagents and related testing materials from Cepheid's GeneXpert...
- The Defense Logistics Agency's Medical Supply Chain awarded a $7,480 firm fixed-price delivery order to Cepheid Inc. for molecular diagnostic solutions, specifically related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The delivery order was executed on August 15, 2025, with an ultimate completion date of August 29, 2025, with performance to be conducted at Cepheid's facility in Sunnyvale, California. No set-aside designation was applied to this contract...
- The Defense Department's Medical Supply Chain awarded an $14.55K firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, for molecular diagnostic solutions supporting COVID-19, influenza, and respiratory syncytial virus (RSV) testing capabilities. The contract, with an ultimate completion date of August 8, 2025, represents a delivery order against Cepheid's existing federal contract vehicles and carries no set-aside designation. Performance will be executed at Cepheid's headquarters...
- The Defense Logistics Agency, under its Medical Supply Chain division, awarded a $13,547.30 firm fixed-price delivery order to Cepheid Inc. on August 14, 2025, for respiratory and influenza diagnostic solutions. The contract, designated as XPCOV2/FLU/RSV-10, is scheduled for completion by August 21, 2025, and will be performed at Cepheid's Sunnyvale, California facility. This delivery order carries no set-aside designation and represents procurement under one of Cepheid's existing federal...
- The U.S. Defense Logistics Agency, operating under the Medical Supply Chain office, awarded a firm fixed-price delivery order valued at $8,840 to Cepheid Inc. on July 29, 2025, with an ultimate completion date of August 5, 2025. This delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic testing solutions, specifically reagents and test kits for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). The contract carries no set-aside designation and will be...
- The Defense Department's Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on July 18, 2025, for molecular diagnostic solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV) testing. The contract, designated as XPCOV2/FLU/RSV-10, represents a delivery order with an ultimate completion date of July 25, 2025, and carries no set-aside designation. Work will be performed at Cepheid's facility in Sunnyvale, California. This award reflects...
- The U.S. Defense Medical Supply Chain awarded a $4,080 firm fixed-price delivery order to Cepheid Inc. on August 11, 2025, for diagnostic testing solutions related to COVID-19, influenza, and respiratory syncytial virus (RSV). This delivery order, with an ultimate completion date of August 18, 2025, carries no set-aside designation and represents a focused procurement of molecular diagnostic products or services from the Sunnyvale, California-based manufacturer. The award likely falls under...
- The U.S. Defense Logistics Agency's Medical Supply Chain division awarded a $3,400 firm fixed-price delivery order to Cepheid Inc. on August 1, 2025, with an ultimate completion date of August 8, 2025. The delivery order, designated XPCOV2/FLU/RSV-10, procures molecular diagnostic solutions for detecting COVID-19, influenza, and respiratory syncytial virus (RSV). Cepheid, a for-profit molecular diagnostics manufacturer headquartered in Sunnyvale, California, specializes in advanced diagnostic...
- SPE2DE24D0013Indefinite Delivery Contract
- SPE2DE24D0013-SPE2D625F1HRADelivery Order
The Defense Logistics Agency's Medical Supply Chain awarded a $30,678.60 firm fixed-price delivery order to Cepheid Inc., a molecular diagnostics manufacturer based in Sunnyvale, California, for COVID-19, Influenza, and Respiratory Syncytial Virus (RSV) testing solutions. The contract, which carries no set-aside designation, was executed on August 19, 2025, with an ultimate completion date of August 26, 2025. This delivery order is likely issued under one of Cepheid's existing Indefinite Delivery Vehicle (IDV) contracts, such as the company's Veterans Integrated Service Network 21 IDV valued at $2.5M, which provides PCR testing capabilities for molecular diagnostics including COVID-19, influenza, RSV, and other infectious disease detection. Cepheid specializes in providing advanced molecular diagnostic systems and reagents to federal healthcare agencies, particularly the Department of Veterans Affairs and Defense Health Agency. The company's GeneXpert diagnostic platform and associated test kits have become integral to federal infectious disease testing across multiple healthcare systems. This delivery order represents a routine procurement of diagnostic reagents and testing materials to support ongoing infectious disease surveillance and patient care within the Department of Defense's medical supply infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $30.7k | 8/19/25 |